Expiry of unlisted options – Jan 2019
Expiry of Unlisted Options
ASX Announcements
Final Director's Interest Notice
Final Director’s Interest Notice
Invitrocue Appoints Professor Masakazu Toi as Clinical Advisor
[:en]EXCERPT: January 11, 2019 – Invitrocue Limited (ASX: IVQ), a leader healthcare bio-analytic solutions provider, is pleased to announce the appointment of Professor Masakazu Toi as Clinical Advisor of Invitrocue. A renowned oncology expert having held various roles as healthcare provider, scholar, and opinion leader, Professor Toi brings strong clinical oncology knowledge and experience especially …
Invitrocue announced Board Changes
[:en]EXCERPT: January 9, 2019 – Invitrocue Limited (ASX : IVQ), a leading healthcare bio-analytic solutions provider, announces the appointment of Dr. Steven Fang as Chairman of the Company’s Board of Directors with immediate effect. Dr. Fang is a co-founder and the Executive Director of Invitrocue with more than 20 years’ experience in leading and building successful …
Change of Director's Interest Notice
Change of Director’s Interest Notice
Change of Director's Interest Notice
Change of Director’s Interest Notice
Change of Director's Interest Notice
Change of Director’s Interest Notice
Change of Director's Interest Notice
Change of Director’s Interest Notice
Change of Director's Interest Notice
Change of Director’s Interest Notice
Change of Director's Interest Notice
Change of Director’s Interest Notice